ConductScience.org, home

Paper14503

Rapid identification of patients with essential hypertension sensitive to acebutolol (a new cardioselective beta-blocker).

Menard J and 4 others. Am J Med, 1976. Cited by 67 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Rapid identification of patients with essential hypertension sensitive to acebutolol (a new cardioselective beta-blocker). Papers, record 14503. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14503

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rapid identification of patients with essential hypertension sensitive to acebutolol (a new cardioselective beta-blocker).
PubMed
Journal
Am J Med
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
67
iCite
Relative citation ratio, by iCite
3.92
iCite
Revised in PubMed
2019-06-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Menard JJ
2Bertagna XX
3N'Guyen PTP T
4Degoulet PP
5Corvol PP

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcebutololMajor topic
Adrenergic beta-AntagonistsMajor topic
HypertensionMajor topic
Adult
Blood Pressure
Depression, Chemical
Female
Heart Rate
Humans
Male
Middle Aged
Posture
Renin

Source PubMed

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.

PMIDTitleJournalYearIn PapersSource
6,840,159Acute antihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6840159PubMed
3,891,306Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.Drugs1985https://conductscience.org/library/papers/3891306PubMed
526,395Labetalol in severe and resistant hypertension.Br J Clin Pharmacol1979https://conductscience.org/library/papers/526395PubMed
508,460Noradrenaline producing phaeochromocytomas with absent pressor response to beta-blockade.Br Heart J1979https://conductscience.org/library/papers/508460PubMed
367,793Acebutolol in hypertension: relationships between drug concentration and effects.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/367793PubMed
359,018Acebutolol in hypertension--double-blind trial against placebo.Br J Clin Pharmacol1978https://conductscience.org/library/papers/359018PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
REN5,972PubTator's text mininghttps://conductscience.org/library/genes/5972

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14503

GET https://conductscience.org/api/papers/v1/14503/authors